Related by context. All words. (Click for frequent words.) 69 renarrowing 68 stent implantation 67 stenting 66 neointimal hyperplasia 65 stent thrombosis 65 stent restenosis 65 reblockage 65 preventing restenosis 64 thrombotic events 63 stented 63 target lesion revascularization 63 sirolimus eluting stent 63 binary restenosis 62 stented vessel 62 reintervention 62 TAXUS Express Stent 62 revascularization 62 neointimal 62 atherosclerotic disease 62 reinfarction 62 paclitaxel eluting stent 61 embolization 61 Restenosis 61 thromboembolic events 61 atherosclerotic lesions 61 sirolimus eluting stents 60 TAXUS Stent 60 thromboembolism 60 angiographic restenosis 60 coronary vessels 60 revascularisation 60 rebleeding 60 segment binary restenosis 60 endovascular repair 60 carotid artery stenting 60 zotarolimus 60 paclitaxel eluting stents 60 trabeculectomy 60 restenosis reblockage 60 stent placement 60 myocardial infarction 59 percutaneous intervention 59 carotid stenting 59 carotid endarterectomy 59 endoleaks 59 periprocedural 59 thrombotic complications 59 perioperative complications 59 drug eluting stents 59 recanalization 59 stenoses 59 contrast induced nephropathy 59 TAXUS 59 bifurcation lesions 59 cerebral vasospasm 59 TAXUS stent 59 CMV disease 59 thromboembolic 59 thrombosis 59 stent 59 paroxysmal AF 59 diameter stenosis 59 endothelialization 58 atherosclerotic 58 colorectal liver metastases 58 hemorrhagic complications 58 ischemic 58 coronary artery disease 58 arterial thrombosis 58 stented artery 58 thrombus formation 58 reclogging 58 repeat revascularization 58 Taxus Stent 58 everolimus eluting stents 58 TACE 58 Target Lesion Revascularization TLR 58 microvascular disease 58 postoperative atrial fibrillation 58 venous thromboembolism 58 percutaneous coronary intervention 58 reoperation 58 thrombogenic 58 saphenous vein grafts 58 bypass graft 57 tumor recurrence 57 postoperative morbidity 57 vein grafts 57 atherosclerotic plaques 57 MACCE 57 XIENCE V PROMUS Stent 57 TAVI 57 stenosis 57 post surgical adhesions 57 STEMI patients 57 aortic stenosis 57 occlusive disease 57 left ventricular dysfunction 57 aneurysms 57 upper gastrointestinal bleeding 57 recurrent VTE 57 tortuosity 57 target vessel revascularization 57 infarct size 57 drug eluting stent 57 myocardial reperfusion 57 distal embolization 57 coronary interventions 57 diseased coronary arteries 57 refractory ischemia 57 nephrotoxicity 57 atherosclerosis 57 mm Stent 57 ventricular remodeling 57 systemic toxicity 57 occlusion 56 Genous stent 56 vasospasm 56 Drug eluting stents 56 tamponade 56 ischemia reperfusion injury 56 platelet reactivity 56 coronary lesions 56 revascularisation procedures 56 ipsilateral stroke 56 aneurysm rupture 56 myocardial ischemia 56 revascularization procedures 56 sidebranch 56 TAXUS Liberté stent 56 fibrinolysis 56 endophthalmitis 56 stent insertion 56 acute coronary syndromes 56 malapposition 56 carotid stenosis 56 DAPT 56 perioperative mortality 56 functional mitral regurgitation 56 reperfusion injury 56 cryptogenic stroke 56 balloon angioplasty 56 severe aortic stenosis 56 arterial plaque 56 vertebral compression fractures 55 atrial arrhythmias 55 thoracic aortic aneurysms 55 reoperations 55 luminal diameter 55 stent DES 55 intracoronary 55 occlusions 55 delayed CINV 55 dual antiplatelet therapy 55 cerebral ischemia 55 transcatheter 55 de novo lesions 55 transurethral resection 55 antiplatelet therapy 55 mitral regurgitation 55 patency 55 endovascular aneurysm repair 55 cardiotoxicity 55 variceal bleeding 55 endarterectomy 55 cardiopulmonary bypass 55 adhesions 55 Sirolimus 55 sirolimus 55 mitral regurgitation MR 55 aortic valve stenosis 55 OPCAB 55 uncoated stents 55 carotid artery disease 55 vascularization 55 antithrombotic therapy 55 thrombi 55 drug zotarolimus 55 stents coated 55 ischaemia 55 clotting 55 ischemic complications 55 hyperkalemia 55 reperfusion 55 postoperative mortality 55 post thrombotic syndrome 55 edifoligide 55 cobiprostone 55 failure TVF 55 surgical revascularization 55 antiplatelet agent 55 cartilage degeneration 55 hemodynamic instability 55 invasive candidiasis 55 ventricular arrhythmias 55 angioplasty stenting 55 mitral stenosis 55 calcified lesions 55 microvascular complications 55 advanced adenomas 55 colorectal adenoma 54 arrhythmias 54 definite stent thrombosis 54 transarterial 54 CRBSI 54 atrial fibrillation 54 cardiac toxicity 54 clot formation 54 vascular inflammation 54 ventricular dysfunction 54 infarctions 54 ostial 54 Acute Myocardial Infarction AMI 54 eptifibatide 54 ximelagatran 54 inserting stent 54 anticoagulation 54 venous blood clots 54 embolic 54 liver resection 54 β blockers 54 aortic 54 cardiovascular hospitalization 54 TAXUS Liberte Stent 54 prostate TURP 54 artery blockages 54 Catheter ablation 54 posterior vitreous detachment 54 XIENCE V stent 54 intravenous bisphosphonates 54 atherothrombotic events 54 multivessel disease 54 intraoperative complications 54 CABG surgery 54 vascular disease 54 stenting procedures 54 reclog 54 infrapopliteal 54 CYPHER ® Stent 54 CYPHER R Stent 54 ischemic stroke 54 CYPHER R Sirolimus eluting 54 acute myocardial infarction AMI 54 coronary disease 54 malperfusion 54 coated stents 54 coronary stenosis 54 tumor resection 54 paroxysmal atrial fibrillation 54 uncoated stent 54 ruptured aneurysms 54 coronary vascular 54 leukotriene pathway 54 intracranial aneurysms 54 blood clots thrombosis 54 balloon valvuloplasty 54 endometrial hyperplasia 54 vessel renarrowing 54 CMV infection 54 Cypher Stent 54 saphenous vein graft 54 endovascular therapy 54 thrombus aspiration 54 RF ablation 54 hypertrophic scars 54 bifurcated lesions 54 postoperative complications 54 anastomotic 54 elevated IOP 54 systolic hypertension 54 CYPHER Stent 54 ischemic cardiomyopathy 54 bone resorption 54 lung metastasis 54 postoperative AF 54 PAOD 54 postoperative infections 54 disease progression 53 coronary stenting 53 arterial thromboembolic events 53 TAXUS Liberte Long 53 atherothrombosis 53 ostium 53 graft occlusion 53 gout flares 53 colorectal tumors 53 PFO closure 53 graft patency 53 varices 53 intimal hyperplasia 53 thrombolytic therapy 53 bowel resection 53 Coronary Stent 53 percutaneous transluminal coronary angioplasty 53 recurrent atrial fibrillation 53 artery stenosis 53 stents BMS 53 atrial fibrillation AF 53 necrotic core 53 carotid artery stenting CAS 53 primary percutaneous coronary 53 thrombolytic agents 53 revascularized 53 atherosclerotic progression 53 acute coronary syndrome 53 asymptomatic carotid stenosis 53 postoperative pulmonary 53 severe hypoglycemia 53 DFMO 53 coronary revascularization 53 reinterventions 53 emboli 53 calcified plaque 53 perioperative morbidity 53 Doxil ® 53 XIENCE V demonstrated 53 diastolic heart 53 pimecrolimus 53 malignant growths 53 everolimus eluting stent 53 revascularizations 53 oncologic outcomes 53 chlorambucil 53 cardiovascular disease 53 CMV reactivation 53 atheroma 53 thrombolysis 53 Events MACE 53 peripheral artery 53 incisional hernias 53 ischemic mitral regurgitation 53 nonobstructive CAD 53 cardiovascular morbidity 53 revascularization procedure 53 GP IIb IIIa inhibitors 53 percutaneous interventions 53 Vascugel ® 53 stenting procedure 53 renal tumors 53 PEGylated interferon beta 1a 53 LV dysfunction 53 acute coronary syndromes ACS 53 fondaparinux 53 transcatheter closure 53 angiographic outcomes 53 rFVIIa 53 myocardial infarction MI 53 protamine 53 CDI recurrence 53 thienopyridines 53 recurrent myocardial infarction 53 indomethacin 53 surgical adhesions 53 grade glioma 53 aneurysm sac 53 adrenalectomy 53 vaso occlusive crisis 53 carotid stents 53 chronic periodontitis 53 ischemia driven 53 dose atorvastatin 53 ventricular tachycardia 53 thromboembolic disease 53 troponin T 53 PSADT 53 beta blocker therapy 53 stent graft 53 Adhibit 53 colorectal polyps 53 cytoreductive surgery 53 distensibility 52 pericardial effusion 52 peri procedural 52 fibrinolytic 52 intracranial stenosis 52 blocked carotid arteries 52 CABG coronary artery 52 patients undergoing CABG 52 anastomotic leak 52 TEVAR 52 abciximab 52 infective endocarditis 52 postoperative ileus 52 thrombolytics 52 coronary artery bypass grafting 52 lumbar spinal stenosis 52 pCR 52 liver metastases 52 repigmentation 52 inflammatory lesions 52 TAXUS Express 52 thromboembolic complications 52 radical nephrectomy 52 cardiogenic shock 52 direct thrombin inhibitors 52 allograft rejection 52 embolic stroke 52 metastatic lesions 52 leiomyomas 52 gouty arthritis 52 carotid endarterectomy CEA 52 mycophenolate mofetil 52 arterial lesions 52 fibrin deposition 52 stent grafts 52 Stent thrombosis 52 deferiprone 52 bezafibrate 52 pulmonary metastases 52 venous thromboembolic events 52 VT VF 52 Candida infections 52 venous reflux 52 renal toxicity 52 octreotide LAR 52 virologic failure 52 thoracoscopic lobectomy 52 pulmonary vasculature 52 sirolimus stent 52 atherogenesis 52 mTOR inhibitors 52 blocked arteries 52 endovascular coiling 52 retroperitoneal 52 neovascularization 52 cerebral aneurysms 52 acute GVHD 52 coronary blockages 52 bypass grafting 52 stent thromboses 52 arterial calcification 52 coil embolization 52 resorption 52 antithrombotic 52 IFN beta 52 saphenous vein 52 serum phosphate 52 cholangiocarcinoma 52 Nitinol Stent 52 pneumonectomy 52 embolic protection 52 minimally invasive technique 52 drug eluting stent DES 52 XIENCE V vs. 52 recurrent venous thromboembolism 52 idraparinux 52 metastatic malignant melanoma 52 DVT PE 52 metastases 52 incisional 52 gastric ulcers 52 unstable angina pectoris 52 infarction 52 nonadherence 52 target lesion revascularizations 52 bioabsorbable stents 52 aortic aneurysms 52 Ebstein anomaly 52 Angiographic 52 TAXUS Express Atom Stent 52 sustained virological response 52 sirolimus eluting 52 lymphadenectomy 52 dexrazoxane 52 Balloon angioplasty 52 coronary artery revascularization 52 retinal detachment 52 colectomy 52 hepatotoxicity 52 bypass grafts 52 locoregional recurrence 52 COPD exacerbations 52 stenotic 52 postoperative pain 52 decompensated heart failure 52 angina pectoris 52 Aortic stenosis 52 invasive coronary angiography 52 VTEs 52 postoperative complication 52 mitral valve replacement 52 choroidal neovascularization 52 candidemia 52 Drug eluting stent 52 NSTE ACS 52 atheroma volume 52 posaconazole 52 CIPN 52 ICD implantation 52 Contrast Induced Nephropathy CIN 52 enoxaparin 52 celecoxib 52 perindopril 52 cardiac dysfunction 52 SUPERA stent 52 biochemical recurrence 52 antiangiogenic 52 thoracic aneurysms 52 nonresponders 52 prostate cancer CaP 52 primary patency 52 lesions 52 SVGs 52 nonvertebral fracture 52 vessel occlusion 51 arrhythmogenic 51 refractory angina 51 atherosclerotic plaque 51 Surgical excision 51 coronary intervention 51 percutaneous coronary interventions 51 tachyarrhythmias 51 arterial occlusion 51 vitrectomy 51 acute STEMI 51 stable angina 51 atherothrombotic 51 Darapladib 51 neoadjuvant therapy 51 ectasia 51 tirofiban 51 thoracic aortic aneurysm 51 stents 51 Sirolimus Eluting Coronary Stent 51 pancreatic adenocarcinoma 51 cardiopulmonary bypass CPB 51 carotid angioplasty 51 arterial inflammation 51 cobalt chromium 51 alteplase 51 GORE VIABAHN Endoprosthesis 51 wound dehiscence 51 arteriovenous malformations 51 angioplasty 51 carotid IMT 51 clopidogrel 51 blocked coronary arteries 51 hypervascular tumors 51 balloon dilation 51 superficial femoral 51 postoperative delirium 51 thromboses 51 olmesartan 51 embolisation 51 GISTs 51 vascular abnormalities 51 thrombectomy 51 CIMZIA ™ 51 Lisofylline 51 arteries atherosclerosis 51 replacement PAVR 51 retransplantation 51 vertebral fracture 51 hypertrophic scarring 51 durable remissions 51 recurrent stroke 51 sternal wound infection 51 lowering homocysteine 51 mitral valve regurgitation 51 renal dysfunction 51 nonoperative 51 adenoma 51 carotid stent 51 metallic stent 51 antibody mediated 51 curative resection 51 thoracic aortic 51 fundoplication 51 transfemoral 51 Embolic Protection System 51 trimethoprim sulfamethoxazole 51 cardiovascular hospitalizations 51 ST elevation myocardial 51 CYPHER ® 51 IOP lowering 51 Radiofrequency ablation 51 ischemia 51 coronary arteries 51 Y gastric bypass 51 INTEGRILIN R 51 vasculopathy 51 systemic embolism 51 antiplatelet drugs 51 STRIDE PD 51 vertebral fractures 51 cardiac tamponade 51 rtPA 51 macrovascular 51 Kyphoplasty 51 minimally invasive endovascular 51 nonvertebral fractures 51 interventionalists 51 platelet inhibition 51 patients undergoing percutaneous 51 superficial bladder cancer 51 CABG 51 undergoing CABG 51 endovascular interventions 51 aortic root replacement 51 neoadjuvant chemotherapy 51 glycated hemoglobin levels 51 nonrandomized 51 fibrotic 51 intraoperatively 51 Percutaneous Coronary Intervention 51 AA Amyloidosis 51 onset diabetes mellitus 51 variceal 51 virologic response 51 lichen planus 51 nondiabetic patients 51 infarcts 51 tumor lysis syndrome 51 abdominal aortic 51 antiarrhythmic drugs 51 lipid lowering drugs 51 vitreous hemorrhage 51 TAXUS Element Stent 51 MitraClip 51 PICSO ® 51 endothelial keratoplasty 51 doxorubicin 51 acne lesions 51 mitral valve repair 51 sustained virologic response 51 sotalol 51 breast cancer metastasis 51 undergoing coronary artery 51 mixed hyperlipidemia 51 limb salvage 51 tachyarrhythmia 51 antegrade 51 macrovascular events 51 drug eluting balloon 51 atherectomy 51 intra arterial 51 mammary tumors 51 drug eluting coronary stents 51 metastatic malignant 51 MitraClip device 51 nonmelanoma skin cancers 51 Stenting 51 fatty plaques 51 Dynesys 51 TAXUS p value 51 bifurcation stent 51 arterial blockage 51 Stents 51 symptomatic intracranial hemorrhage 51 recurrent ischemia 51 percutaneous aortic valve 51 contralateral breast 51 ALND 51 collagen degradation 51 percutaneous 51 ventricular tachyarrhythmia 51 bioresorbable 51 iliac artery disease 51 silent ischemia 51 intravesical therapy 51 myocardial infarction stroke 51 dilatation 51 fluid overload 51 tPA 51 morphometric vertebral fractures 51 intracerebral hemorrhage 51 NEVO ™ 51 coronary artery bypass grafts 51 corneal ectasia 51 venous thrombosis 51 Thrombocytopenia 51 endotoxemia 51 bacteriuria 51 clot busters 51 unfractionated heparin 51 losartan 51 extracranial 51 adenoma recurrence 51 androgen deprivation 51 Hypotension 51 epicardial 51 pulmonary hypertension PH 51 surgical decompression 51 cobalt chromium stent 51 colon tumors 51 acute ischemic stroke 51 demyelination 51 coronary sinus 51 bosentan 51 kainate 51 antiangiogenic agent 51 tolvaptan 51 coronary 51 TNF antagonist 51 physis 50 penetrating keratoplasty 50 adenoidectomy 50 NATRECOR ® 50 intracranial hemorrhage ICH 50 detrusor overactivity 50 recurrent glioblastoma multiforme 50 denervation 50 R0 resection 50 parathyroid carcinoma 50 hypercalcemia 50 platelet activation 50 Erythropoietic therapies may 50 distal lesions 50 bivalirudin 50 polypoid 50 UA NSTEMI 50 NSAID induced 50 fibrosis 50 fistulae 50 adalimumab 50 PlGF 50 MS relapses 50 infarction STEMI 50 endometrial carcinoma 50 nonischemic 50 VAPRISOL 50 myocyte 50 valvular disease 50 lipid lowering therapies 50 seroma 50 thrombus 50 Aprotinin 50 atypical fractures 50 defibrotide 50 tecarfarin 50 EUS FNA 50 EBRT 50 uveal melanoma 50 anticoagulated 50 coronary artery stenting 50 hyperglycaemia 50 tricuspid regurgitation 50 myocardial infarctions 50 Sirolimus eluting Coronary Stent 50 aortic annulus 50 APTIVUS r 50 renal arteries 50 elective PCI 50 intima media thickness 50 eluting stent 50 SYNTAX trial 50 valve implantation 50 colon polyps 50 VA# [002] 50 Atherosclerotic 50 rt PA 50 recombinant tissue plasminogen 50 diabetic retinopathy DR 50 nocturnal hypoglycaemia 50 palliation 50 ertapenem 50 teriflunomide 50 carotid plaque 50 mitomycin C 50 virological failure 50 femoral shaft fractures 50 Thal Dex 50 keloid scarring treatment 50 preterm delivery 50 periprocedural MI 50 coronary artery 50 carotid artery blockage 50 eluting stents 50 post operatively 50 teriparatide 50 breast cancer recurrence 50 coronary anatomy 50 dissolve clots 50 radioiodine therapy 50 occluded artery 50 haematopoietic 50 DU #b 50 unruptured aneurysms 50 biliary strictures 50 severe mitral regurgitation 50 variceal hemorrhage 50 fistulas 50 Carotid stenting 50 Critical limb ischemia 50 deep venous thromboses 50 circulating EPCs 50 metastatic renal cell carcinoma 50 POAG 50 fibrotic disease 50 systemic corticosteroids 50 catheter ablation 50 oral leukoplakia 50 overlapping stents 50 proliferative diabetic retinopathy 50 antiarrhythmic drug 50 microvascular 50 amyloid plaque 50 peripheral vasculature 50 LMWH 50 DSAEK 50 laparoscopic adjustable gastric banding 50 Drug coated stents 50 FOLFOX4 50 microglial activation 50 aortic regurgitation 50 verapamil 50 esophageal lesions 50 elevated triglyceride levels 50 TNF α 50 Minimally invasive surgery 50 neoplasia 50 aortic rupture 50 paricalcitol 50 Statin therapy 50 antiplatelet agents 50 hypercholesterolemia 50 directed thrombolysis 50 IV bisphosphonates 50 hypertrophic 50 aortic insufficiency 50 hyperacute 50 pulmonary veins 50 hepatic metastases 50 prolonged QT interval 50 chemoembolization 50 clodronate 50 bioresorbable polymer 50 invasive aspergillosis 50 dronedarone 50 amyloid deposition 50 percutaneously 50 ventricular arrhythmia 50 Tyrima 50 mechanical thrombectomy 50 catheter angiography 50 pseudoaneurysm 50 metaglidasen 50 hyperphosphatemia 50 acute aortic dissection 50 bioprostheses 50 coronary stenoses 50 polyp recurrence 50 plasma uric acid 50 tumor regrowth 50 lowering blood glucose 50 resections 50 distant metastases 50 coated stent 50 Inosine 50 Intracranial 50 postoperative bleeding 50 gastrointestinal toxicity 50 hepatocellular 50 acne vulgaris 50 Duodenal 50 vWF 50 interferon IFN 50 deep venous thrombosis 50 arterial plaques 50 bioabsorbable polymer 50 Ischemic 50 geographic atrophy 50 rehospitalization 50 recurrent DVT 50 ischemic reperfusion injury 50 hyperalgesia 50 Zilver stent 50 neovascular 50 paclitaxel coated 50 peripheral arteries 50 osteoid osteoma 50 pulmonary emboli 50 bi ventricular pacing 50 treat brain aneurysms 50 metastatic RCC 50 transthoracic 50 RVOT 50 cinacalcet 50 central retinal vein 50 angiogenesis inhibitor 50 Mitral valve 50 lung tumors 50 OGG1 50 VTE 50 stent struts 50 radiofrequency ablation 50 adenomas 50 prolongs survival 50 thrombotic 50 TNFa 50 platelet inhibitor 50 endobronchial 50 occlusion CRVO 50 paraganglioma 50 lowering LDL cholesterol 50 esophageal perforation 50 Dronedarone 50 SHPT 50 ABSORB trial 50 vascular 50 imatinib therapy 50 biphosphonates 50 unclog arteries 50 lung metastases 50 atrioventricular valve 50 cataract formation 50 Stenosis 50 chemoradiotherapy 50 rhBMP 2 50 Combo Stent 50 induce regression 50 jejunal 50 drug eluting stent implantation 50 osteoclast activity 50 oral anticoagulation 50 InterStim Therapy 50 recurrent GBM 50 annualized relapse 50 Symadex 50 bypass graft surgery 50 TLIF 50 serum urate levels 50 platinum coils 50 postoperative infection 50 CA4P 50 neovascularisation 50 secondary hyperparathyroidism 50 disc degeneration 50 adjuvant radiotherapy 50 paracentesis 50 vasodilators 50 Rivaroxaban 50 preterm deliveries 50 ureteroscopy 50 riociguat 50 calculi 50 LY# [003] 50 lumbar interbody fusion 50 narrowed carotid arteries 50 laser photocoagulation 50 pheochromocytoma 50 corticosteroid therapy 50 VEGF inhibitors 50 medicated stents 50 Dasatinib 50 GORE TAG Device 50 lipid lowering therapy 50 lung resection 50 zotarolimus eluting stent 50 thrombolytic 50 Occlusions 50 photocoagulation 50 left ventricular hypertrophy 49 nephrotoxic 49 atherothrombotic disease 49 severe neutropenia 49 conventional coronary angiography 49 Endarterectomy 49 radial artery grafts 49 mucinous 49 Aneurysms 49 myeloperoxidase 49 hemorrhagic strokes 49 Biolimus A9 49 Stent System 49 Carotid artery 49 AV grafts 49 coronary plaques 49 dyskinetic 49 colon resection 49 cirrhotic patients 49 menstrual migraine 49 osteolysis 49 plasma kallikrein 49 intra ocular pressure 49 renal cell carcinomas 49 TZDs 49 diabetic gastroparesis 49 deferoxamine 49 invasive fungal infections 49 reperfusion therapy 49 transplantation HCT 49 coronary arterial 49 CP CPPS 49 balloon dilatation 49 cerebral vascular 49 choroidal neovascularization CNV 49 AV fistulas 49 partial nephrectomy 49 bisphosphonate therapy 49 calcified plaques 49 esophagogastric 49 anastomotic devices 49 aneurysmal 49 Endoprosthesis 49 nonfatal MI 49 intravitreal injections 49 TAVR 49 prednisone prednisolone